BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 1688906)

  • 1. Localization of and immune response to the lipid-modified azurin of the pathogenic Neisseria.
    Trees DL; Spinola SM
    J Infect Dis; 1990 Feb; 161(2):336-9. PubMed ID: 1688906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neisserial antigen H.8 is immunogenic in patients with disseminated gonococcal and meningococcal infections.
    Black JR; Black WJ; Cannon JG
    J Infect Dis; 1985 Apr; 151(4):650-7. PubMed ID: 3919117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Localization of a conserved epitope and an azurin-like domain in the H.8 protein of pathogenic Neisseria.
    Kawula TH; Spinola SM; Klapper DG; Cannon JG
    Mol Microbiol; 1987 Sep; 1(2):179-85. PubMed ID: 2452958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid-modified azurin of Neisseria meningitidis is a copper protein localized on the outer membrane surface and not regulated by FNR.
    Deeudom M; Huston W; Moir JW
    Antonie Van Leeuwenhoek; 2015 Apr; 107(4):1107-16. PubMed ID: 25666376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the neisserial lipid-modified azurin bearing the H.8 epitope.
    Woods JP; Dempsey JF; Kawula TH; Barritt DS; Cannon JG
    Mol Microbiol; 1989 May; 3(5):583-91. PubMed ID: 2474741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal antibody that recognizes an outer membrane antigen common to the pathogenic Neisseria species but not to most nonpathogenic Neisseria species.
    Cannon JG; Black WJ; Nachamkin I; Stewart PW
    Infect Immun; 1984 Mar; 43(3):994-9. PubMed ID: 6421742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disrupting the entry barrier and attacking brain tumors: the role of the Neisseria H.8 epitope and the Laz protein.
    Hong CS; Yamada T; Hashimoto W; Fialho AM; Das Gupta TK; Chakrabarty AM
    Cell Cycle; 2006 Aug; 5(15):1633-41. PubMed ID: 16861907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunization with recombinant truncated Neisseria meningitidis-Macrophage Infectivity Potentiator (rT-Nm-MIP) protein induces murine antibodies that are cross-reactive and bactericidal for Neisseria gonorrhoeae.
    Humbert MV; Christodoulides M
    Vaccine; 2018 Jun; 36(27):3926-3936. PubMed ID: 29803329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of epitopes recognized by monoclonal antibodies SM1 and SM2 which react with all pili of Neisseria gonorrhoeae but which differentiate between two structural classes of pili expressed by Neisseria meningitidis and the distribution of their encoding sequences in the genomes of Neisseria spp.
    Virji M; Heckels JE; Potts WJ; Hart CA; Saunders JR
    J Gen Microbiol; 1989 Dec; 135(12):3239-51. PubMed ID: 2483993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence of serum antibodies to Neisseria gonorrhoeae before gonococcal infection.
    Hicks CB; Boslego JW; Brandt B
    J Infect Dis; 1987 Jun; 155(6):1276-81. PubMed ID: 2883240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Common epitopes of pilin of Neisseria meningitidis.
    Stephens DS; Whitney AM; Schoolnik GK; Zollinger WD
    J Infect Dis; 1988 Aug; 158(2):332-42. PubMed ID: 2457056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Azurin of pathogenic Neisseria spp. is involved in defense against hydrogen peroxide and survival within cervical epithelial cells.
    Wu HJ; Seib KL; Edwards JL; Apicella MA; McEwan AG; Jennings MP
    Infect Immun; 2005 Dec; 73(12):8444-8. PubMed ID: 16299348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complement interactions with the pathogenic Neisseriae: clinical features, deficiency states, and evasion mechanisms.
    Lewis LA; Ram S
    FEBS Lett; 2020 Aug; 594(16):2670-2694. PubMed ID: 32058583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enzyme-linked immunosorbent assays for the detection of Neisseria gonorrhoeae specific antibodies.
    Brodeur BR; Ashton FE; Diena BB
    Can J Microbiol; 1978 Nov; 24(11):1300-5. PubMed ID: 105793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surface proteins of pathogenic "Neisseria": antigenic variation and conserved epitopes.
    Meyer TF; Haas R; Stern A; Fiedler H; Frosch M; Jähnig F; Muralidharan K; Veit S
    Ann Sclavo Collana Monogr; 1986; 3(1-2):407-14. PubMed ID: 2447924
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of methods for the analysis of outer membrane antigens of Neisseria meningitidis by western blotting.
    Davies RL; Wall RA; Borriello SP
    J Immunol Methods; 1990 Dec; 134(2):215-25. PubMed ID: 1701470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pili of Neisseria meningitidis. Analysis of structure and investigation of structural and antigenic relationships to gonococcal pili.
    Stephens DS; Whitney AM; Rothbard J; Schoolnik GK
    J Exp Med; 1985 Jun; 161(6):1539-53. PubMed ID: 2409203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and characterization of a cross-reactive and a unique B-cell epitope on the hsp60 homologue from Neisseria gonorrhoeae.
    Pannekoek Y; Dankert J; van Putten JP
    FEMS Microbiol Lett; 1992 Nov; 78(1):23-9. PubMed ID: 1281800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunization with recombinant Chaperonin60 (Chp60) outer membrane protein induces a bactericidal antibody response against Neisseria meningitidis.
    Phillips R; Williams JN; Tan WM; Bielecka MK; Thompson H; Hung MC; Heckels JE; Christodoulides M
    Vaccine; 2013 May; 31(22):2584-90. PubMed ID: 23566947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction between Neisseria gonorrhoeae bacterial peroxidase and its electron donor, the lipid-modified azurin.
    Nóbrega CS; Pauleta SR
    FEBS Lett; 2018 May; 592(9):1473-1483. PubMed ID: 29665008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.